Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,871,688
-$527,134 QoQ
Shares Held
61,514
-1.9% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. TARS ranks #75 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,871,688 61,514
2026-03-31 $4,398,822 62,706
2025-12-31 $5,431,507 66,335
2025-09-30 $3,720,494 62,603
2025-06-30 $3,499,170 86,378
2025-03-31 $3,658,570 71,220
2024-12-31 $3,866,265 69,826
2024-09-30 $1,935,081 58,835
2024-06-30 $1,443,963 53,126
2024-03-31 $825,872 22,720